Telithromycin inhibition of protein synthesis and 50S ribosomal subunit formation in Streptococcus pneumoniae cells

被引:14
作者
Champney, WS [1 ]
Pelt, J [1 ]
机构
[1] E Tennessee State Univ, James H Quillen Coll Med, Dept Biochem & Mol Biol, Johnson City, TN 37614 USA
关键词
D O I
10.1007/s00284-002-3710-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The new ketolide antibiotic telithromycin (HMR3647) has been examined for inhibitory effects in cells of Streptococcus pneumoniae. The antibiotic caused a proportional decline in cell growth rate and viability with an IC50 of 15 ng/ml. At a concentration of 7.5 ng/ml, protein synthesis in these cells was reduced by 50%. As seen in other organisms, this compound was also a very effective inhibitor of the formation of the 50S ribosomal subunit in growing cells. Pulse and chase labeling assays defined the reduced rate of 50S synthesis in antibiotic treated cells. At 7.5 ng/ml the rate was reduced to 50% of the control synthesis rate. An IC50 of 15 ng/ml was found for the effect on this process. 30S ribosomal subunit formation was unaffected by the antibiotic. Inhibition of translation and 50S particle formation are equivalent targets for this antibiotic. The effects of telithromycin in S. pneumoniae are compared with those found in Staphylococcus aureus cells.
引用
收藏
页码:328 / 333
页数:6
相关论文
共 38 条
[1]  
AMABILECUEVAS CF, 1995, AM SCI, V83, P320
[2]   ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - AN OVERVIEW [J].
APPELBAUM, PC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :77-83
[3]   Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin) [J].
Barry, AL ;
Fuchs, PC ;
Brown, SD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) :945-946
[4]   Ketolides lack inducibility properties of MLSB resistance phenotype [J].
Bonnefoy, A ;
Girard, AM ;
Agouridas, C ;
Chantot, JF .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :85-90
[5]   The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent [J].
Boswell, FJ ;
Andrews, JM ;
Ashby, JP ;
Fogarty, C ;
Brenwald, NP ;
Wise, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (06) :703-709
[6]  
Bryskier A, 1997, INFEC DIS T, V21, P39
[7]   Studies of the novel ketolide ABT-773:: Transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae [J].
Capobianco, JO ;
Cao, ZS ;
Shortridge, VD ;
Ma, ZK ;
Flamm, RK ;
Zhong, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1562-1567
[8]   A comparison of the inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by nine different macrolide antibiotics [J].
Champney, WS ;
Tober, CL ;
Burdine, R .
CURRENT MICROBIOLOGY, 1998, 37 (06) :412-417
[9]   Inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by 11 different ketolide antibiotics [J].
Champney, WS ;
Tober, CL .
CURRENT MICROBIOLOGY, 1998, 37 (06) :418-425
[10]  
Champney WS, 2001, CURR MICROBIOL, V42, P203